(Q35159037)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Decreasing smoking behaviour and risk through CYP2A6 inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Rachel F Tyndale

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Leona C Fernandes

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

487-493

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

Tobacco and the global lung cancer epidemic

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

At least one in seven cases of cancer is caused by smoking. Global estimates for 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Tobacco use, cancer causation and public health impact

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Molecular epidemiology of smoking and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

World Health Organization takes on 'tobacco epidemic'

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

The human and financial costs of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

The genetics of smoking persistence in men and women: a multicultural study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Smoking behaviour and compensation: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Cigarette Smoking: A Dependence on High-Nicotine Boli

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Pharmacologic determinants of tobacco self-administration by humans

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Smokers of low-yield cigarettes do not consume less nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Clinical pharmacokinetics of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Transdermal nicotine: reduction of smoking with minimal abuse liability.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Determinants of nicotine intake while chewing nicotine polacrilex gum

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Stable isotope method for studying transdermal drug absorption: the nicotine patch

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System)

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Serum nicotine and cotinine levels during nicotine-patch therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

CYP2A6 genetic variation and potential consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Polymorphisms of CYP2A6 and its practical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Nicotine metabolism and intake in black and white smokers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Nicotine metabolism and CYP2A6 allele frequencies in Koreans

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Nicotine metabolism defect reduces smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

The use of long PCR to confirm three common alleles at the CYP2A6 locus and the relationship between genotype and smoking habit

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Tobacco smoke carcinogens and lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Stable isotope studies of nicotine kinetics and bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Reduced smoking--an acceptable goal for the hopeless heavy smoker?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Effects of nicotine chewing gum on cigarette smoking and subjective and physiologic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

Nicotine delivery kinetics and abuse liability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902704-1

7 January 2021

10.1016/S1359-6446(03)02704-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12818518%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference